← FDA Drug Approvals (Drugs@FDA)

SUMATRIPTAN SUCCINATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2009-09-18

Drug application

FDA Application #

ANDA079240

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUMATRIPTAN SUCCINATE

Generic name

Sumatriptan Succinate

Active ingredients

SUMATRIPTAN SUCCINATE

Dosage form

INJECTABLE

Route

SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

FRESENIUS KABI USA

First approval

2009-09-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown